Realtime | Geld | Brief | Zeit |
---|---|---|---|
6,050 | 6,300 | 11:29 | |
6,050 | 6,300 | 10:43 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
22.04. | What Made White Falcon Hold Lifecore Biomedical (LFCR)? | 1 | Insider Monkey | ||
19.04. | Lifecore Biomedical gets Nasdaq notice regarding delayed quarterly report | 1 | Seeking Alpha | ||
19.04. | Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report | 62 | GlobeNewswire (Europe) | CHASKA, Minn., April 19, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the "Company") announced today that, on April 15, 2024, the Company received a notification letter (the... ► Artikel lesen | |
19.04. | LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report | 1 | SEC Filings | ||
08.04. | LIFECORE BIOMEDICAL, INC. \DE\ - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | 1 | SEC Filings | ||
01.04. | LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report | 1 | SEC Filings | ||
26.03. | Lifecore Biomedical, Inc.: Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update | 46 | GlobeNewswire (Europe) | CHASKA, Minn., March 26, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore" or the "Company"), a fully integrated contract development and manufacturing organization ("CDMO")... ► Artikel lesen | |
21.03. | Lifecore (LFCR) Down 30% on Ending Strategic Review With No Deal | 1 | Zacks | ||
20.03. | Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | 2 | Benzinga.com | ||
20.03. | CDMO Lifecore Biomedical names new CEO, board chair after year-long strategic review | 3 | FiercePharma | ||
20.03. | Lifecore Biomedical: Board Concludes Review; To Execute Strategic Plan As Standalone Company | 2 | RTTNews | ||
20.03. | Lifecore Biomedical concludes strategic evaluation process, names new CEO | 1 | Seeking Alpha | ||
20.03. | Lifecore Biomedical revises past financial statements | 3 | Investing.com | ||
20.03. | Lifecore Biomedical, Inc.: Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes | 1 | GlobeNewswire (USA) | ||
20.03. | Lifecore Biomedical, Inc.: Lifecore Biomedical Completes Restatements and Files Form 10-K for Fiscal Year 2023 | 295 | GlobeNewswire (Europe) | CHASKA, Minn., March 20, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore"or the"Company"), a fully integrated contract development and manufacturing organization ("CDMO")... ► Artikel lesen | |
20.03. | LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report | 1 | SEC Filings | ||
16.02. | Lifecore faces potential Nasdaq delisting over filing delays | 2 | Investing.com | ||
16.02. | Lifecore Biomedical receives Nasdaq notice of delisting | 1 | Seeking Alpha | ||
16.02. | LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report | 1 | SEC Filings | ||
16.02. | Lifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal | 337 | GlobeNewswire (Europe) | CHASKA, Minn., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the "Company") announced today that on February 13, 2024 it received a Staff Delisting Determination (the... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PVA TEPLA | 18,570 | +0,11 % | PVA Tepla-Aktie leicht im Plus (18,06 €) | An der deutschen Börse notiert der Anteilsschein von PVA Tepla gegenwärtig fester. Der jüngste Kurs betrug 18,06 Euro. Ein Kursplus in Höhe von 48 Cent erfreut derzeit die Aktionäre von PVA Tepla. Der... ► Artikel lesen | |
IROBOT | 7,364 | +1,21 % | Battle of the best robovacs (that iRobot doesn't make) | ||
VA-Q-TEC | 23,500 | +1,73 % | UNGLAUBLICHE Sondermeldung bei Va-Q-tec Aktie: DAS erwischt Anleger heute eiskalt. Dringend lesen und reagieren! | ||
VECTRON | 8,100 | -0,49 % | Lok-Leasing: Kern vergrößert Vectron-Flotte | ||
IDENTIV | 4,830 | +0,62 % | Identiv, Inc. - 8-K, Current Report | ||
AXON ENTERPRISE | 287,20 | -0,28 % | Söllner: "Neue KI-Waffe" Nvidia, Xiaomi, "Fusionsreaktor!", Porsche-Wunder, Apple, Tesla, Kion, Axon | Florian Söllner, leitender Redakteur bei DER AKTIONÄR, blickt jede Woche auf die spannendsten Entwicklungen im Tech-Sektor. Heute geht es um folgende Werte: Nvidia, Bilfinger, Siemens Energy, Tesla... ► Artikel lesen | |
AKER CARBON CAPTURE | 0,600 | +1,18 % | With CFO on the move, Aker Carbon Capture picks interim one | ||
ZEBRA TECHNOLOGIES | 277,10 | -0,18 % | Zebra Technologies (ZBRA) to Post Q1 Earnings: What to Expect | ||
SARTORIUS AG VZ | 294,50 | +1,48 % | DAX leicht höher erwartet: SAP, Lufthansa, Adidas, Sartorius, Daimler Truck und Tesla im Fokus | Der DAX ist am Freitag im Zuge der zunehmenden geopolitischen Sorgen der Anleger mit einem Minus von 0,6 Prozent auf 17.737,36 Zählern aus dem Handel gegangen. Auf Wochensicht bedeutete dies ein Minus... ► Artikel lesen | |
MICROCLOUD HOLOGRAM | 2,500 | 0,00 % | Peering Into MicroCloud Hologram's Recent Short Interest | ||
EVOLV TECHNOLOGIES | 4,125 | 0,00 % | Evolv Technology Reports Record Fourth Quarter and Full Year Financial Results | WALTHAM, Mass.--(BUSINESS WIRE)--Evolv Technology (NASDAQ: EVLV), the leading security technology company pioneering AI-based weapons detection to create safer experiences, today announced financial... ► Artikel lesen | |
DRONESHIELD | 0,504 | -3,45 % | XFRA DRH: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
BYRNA TECHNOLOGIES | 13,665 | 0,00 % | Byrna Technologies promotes Brasseur to COO | ||
KLA | 665,90 | +0,96 % | KLA mit erneutem Umsatzrückgang, aber positivem Ausblick für Halbleiterbranche | MILPITAS, Kalifornien (IT-Times) - Der US-amerikanische Halbleiterausrüster KLA Corp. hat seine Ergebnisse für das dritte Quartal 2023/2024 veröffentlicht und wies einen kleinen Rückgang beim Umsatz... ► Artikel lesen | |
SERVE ROBOTICS | 2,990 | 0,00 % | Aegis Capital Corp. acted as Sole Bookrunner on a $40 Million Public Offering and Uplisting to Nasdaq for Serve Robotics Inc. | NEW YORK, NY / ACCESSWIRE / April 25, 2024 / Aegis Capital Corp. acted as Sole Bookrunner on a $40 Million Public Offering and Uplisting to Nasdaq for Serve Robotics Inc. (NASDAQ: SERV). About Serve... ► Artikel lesen |